BIORESTORATIVE THERAPIES ($BRTX) is expected to release its quarterly earnings data on Thursday, March 27th after market close, per Finnhub. Analysts are expecting revenue of $484,500 and earnings of -$0.28 per share.
You can see Quiver Quantitative's $BRTX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BIORESTORATIVE THERAPIES Insider Trading Activity
BIORESTORATIVE THERAPIES insiders have traded $BRTX stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $BRTX stock by insiders over the last 6 months:
- DALE BROADRICK sold 1,112 shares for an estimated $1,756
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BIORESTORATIVE THERAPIES Hedge Fund Activity
We have seen 4 institutional investors add shares of BIORESTORATIVE THERAPIES stock to their portfolio, and 6 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC added 21,481 shares (+inf%) to their portfolio in Q4 2024, for an estimated $30,717
- RENAISSANCE TECHNOLOGIES LLC removed 20,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $28,600
- UBS GROUP AG added 15,604 shares (+2251.7%) to their portfolio in Q4 2024, for an estimated $22,313
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 12,774 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $18,266
- MORGAN STANLEY added 10,000 shares (+57.1%) to their portfolio in Q4 2024, for an estimated $14,300
- OSAIC HOLDINGS, INC. removed 2,000 shares (-91.2%) from their portfolio in Q4 2024, for an estimated $2,860
- NEWMAN DIGNAN & SHEERAR, INC. added 1,000 shares (+9.5%) to their portfolio in Q4 2024, for an estimated $1,430
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
